Loading
Life sciences · Journal article
Frontiers in Immunology · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Childhood obesity has become a major global public health concern. It is an early-onset systemic immunometabolic disorder closely associated with multi-organ complications, including insulin resistance and cardiovascular disease (CVD). By linking adipose tissue immune remodeling with gut microbiota dysbiosis, this review proposes the gut microbiota-immune axis as an integrative framework connecting obesity-associated immunometabolic disturbances to multi-organ complications. It further explains how local pathological changes in adipose tissue may progressively develop into systemic inflammation and multi-organ damage. Mechanistically, adipocyte hypertrophy, oxidative stress, and lipolysis initiate local adipose tissue remodeling, characterized predominantly by pro-inflammatory M1 macrophage polarization and activation of the Th1/Th17 pathways. Concurrently, diet-induced gut dysbiosis impairs the intestinal barrier, promotes metabolic endotoxemia, and reduces short-chain fatty acid (SCFA) production. Adipose tissue immune remodeling and gut microbiota dysbiosis may establish a bidirectional immunometabolic feedback loop that sustains systemic metaflammation. This review examines the regulatory role of the gut microbiota-immune axis in obesity, delineates differences and evidence gaps between pediatric and adult obesity, and compares the shared and organ-specific mechanisms underlying various complications. Pediatric-specific biomarkers and emerging intervention strategies are also summarized. Collectively, these findings provide a conceptual basis for early risk screening in childhood obesity and for the prevention and management of obesity-related complications.